We are very pleased to invite you to participate in the International Conference “BIOMEMBRANES 2016: Mechanisms of Aging and Age-Related Diseases”, which will be held at Moscow Institute of Physics and Technology (MIPT), Russia, Dolgoprudny on September 26-30, 2016.

A major goal of this conference is to provide up-to-date information about research on biomembranes and to consolidate cross-disciplinary international scientific efforts in this field. Our speakers will focus on cutting-edge problems of modern integrative structural biology of biomembranes and membrane proteins, theoretical biophysics of membrane systems and computer modelling. The conference will highlight the role of biomembranes in aging and age-related diseases such as cancer, neurodegenerative (Alzheimer’s, Parkinson’s) and cardiovascular diseases.

Research on biological membranes occupies a central position in cellular and molecular biology. Biomembranes form very complex, dynamic and heterogeneous structures, in both space and time, critical for cellular function. Membrane proteins are involved in transport of ions and nutrients, signal transduction and energy conversion, and their malfunctions often result in numerous serious diseases, such as Alzheimer’s, Parkinson’s, diabetes, cancers, heart failure and others. While membrane proteins represent roughly one-third of the proteins encoded in the human genome, about 70% of modern drugs target these proteins, emphasizing their crucial value for pharmacology and medicine. Biological membranes are also a focus of intense investigations in soft matter and theoretical physics.

X-ray and neutron scattering, NMR, electron microscopy, mass-spectrometry and single molecule fluorescence spectroscopy are key methods to study
structural aspects and functional mechanisms of membrane proteins at time resolutions from femtoseconds to minutes, and spatial scales from atoms to whole organisms. The last few years have brought multiple breakthroughs in instrumentation and technologies, enabling the pursuit of new irections and paradigms in a variety of fields including studies of biological membranes.

We are happy to inform you that organizing committee has a possibility to reduce the Fee for academic researchers to 1000 Rub.

Fee for non-academic / industrial and other participants is 4000 Rub.

Students (including PhD students) are exempt from Fee.

Participants, who pay the conference Fee, will get the conference set: conference materials, book of abstracts, souvenirs. In addition, the Russian edition of “Methods in Molecular Biophysics: Structure, Dynamics, Function” by I. N. Serdyuk, N. R. Zaccai, J. Zaccai will be proposed as a gift. The number of sets is limited.

Fee-free participants (students and PhD students) can obtain the conference set for 700 Rub at the registration desk on September 26-27.

The fee may be paid in cash in rubles during registration on September 26-27.

We kindly invite our registered participants to participate in the poster sessions.

Preferred poster size is A0 (portrait orientation).

Posters will be posted up in the coffee breaks hall.

Valentin Borshchevskiy (MIPT) – Сhairman

Andrey Rogachev (MIPT / JINR) – Co-chairman

Tatiana Murugova (JINR / MIPT) – Scientific secretary

Alexey Mishin (MIPT)

Ivan Okhrimenko (MIPT)

Eugenia Chrikina (MIPT)

Margarita Zaytseva (MIPT)

Nina Malyar (MIPT)

Alexandra Luginina (MIPT)

Pavel Kuzmichev (MIPT)

Vladimir Chupin (MIPT)

Oleksandr Ivankov (JINR / MIPT)

Nikolay Ilyinsky (MIPT)

Mikhail Shevtsov (MIPT)

Anastasia Gusach (MIPT)

Valentin Gordeliy (MIPT / IBS, France / FZJ / RWTH, Germany) – Chairman

Norbert Dencher (TU Darmstadt, Germany) – Co-chairman

Georg Büldt (MIPT)

Vadim Cherezov (Bridge Institute USC, USA / MIPT)

Michiru D. Sugawa (Charité - University Medicine Berlin, Germany / Chiba University, Japan)

Dieter Willbold (FZJ, Germany)

Alexey Rak (Sanofi R&D, France)

Raymond Stevens (Bridge Institute, USC, USA)

Ernst Bamberg (MPI of Biophysics, Germany)

Vladimir Skulachev (MSU, Russia)

Anatoly Yashin (Duke University, USA)

Lorenz Mayr (AstraZeneca, UK)

Vladimir Anisimov (Petrov Research Institute of Oncology, Russia)